Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05130866 |
| Title | Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas (POPLAR-NF2) |
| Acronym | POPLAR-NF2 |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Recursion Pharmaceuticals Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | child | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| House Institute | Los Angeles | California | 90057 | United States | Details | |
| University of California Los Angeles | Los Angeles | California | 90095 | United States | Details | |
| Children's National Hospital | Washington D.C. | District of Columbia | 20010 | United States | Details | |
| University of Florida | Gainesville | Florida | 32611 | United States | Details | |
| Nicklaus Children's Hospital | Miami | Florida | 33155 | United States | Details | |
| Sarah Cannon Cancer Institute - HCA Midwest | Overland Park | Kansas | 66211 | United States | Details | |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States | Details | |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | United States | Details | |
| University of Minnesota / Masonic Cancer Center | Minneapolis | Minnesota | 55455 | United States | Details | |
| Mayo Clinic | Rochester | Minnesota | 55905 | United States | Details | |
| Columbia University | New York | New York | 10032 | United States | Details | |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
| Duke University Medical Center | Durham | North Carolina | 27710 | United States | Details | |
| UT Southwestern Medical Center | Dallas | Texas | 75390 | United States | Details |